China NMPA Product Recall - Chronic lymphocytic leukemia chromosome and gene abnormality detection kit (in situ hybridization method)
China NMPA product recall for Chronic lymphocytic leukemia chromosome and gene abnormality detection kit (in situ hybridization method) by Abbott Trading (Shanghai) Co., Ltd. published August 12, 2021. Recall level: Level 2 Recall. Abbott Trading (Shanghai) Co., Ltd. announced a voluntary Class II recall of its Chronic Lymphoblast
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Chronic lymphocytic leukemia chromosome and gene abnormality detection kit (in situ hybridization method) by Abbott Trading (Shanghai) Co., Ltd. published August 12, 2021. Recall level: Level 2 Recall. Abbott Trading (Shanghai) Co., Ltd. announced a voluntary Class II recall of its Chronic Lymphoblast
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox